Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis

Kodali, Susheel; H. Thourani, Vinod; White, Jonathon; Chris Malaisrie, S.; Lim, Scott; L. Greason, Kevin; Williams, Mathew; Guerrero, Mayra; C. Eisenhauer, Andrew; Kapadia, Samir; J. Kereiakes, Dean; C. Herrmann, Howard; Babaliaros, Vasilis; Y. Szeto, Wilson; T. Hahn, Rebecca; Pîbarot, Philippe; J. Weissman, Neil; Leipsic, Jonathon; Blanke, Philipp; Whisenant, Brian; M. Suri, Rakesh; Makkar, Raj; Ayele, Girma; G. Svensson, Lars; G. Webb, John; J. Mack, Michael; R. Smith, Craig; B. Leon, Martin

doi:10.1093/eurheartj/ehw112

Public

Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis

Published in European Heart Journal • Mar 31, 2016

Authors:

Susheel Kodali

Vinod H. Thourani

Jonathon White

Abstract

AIMS: Based on randomized trials using first-generation devices, transcatheter aortic valve replacement (TAVR) is well established in the treatment of high-risk (HR) patients with severe aortic stenosis (AS). To date, there is a paucity of adjudicated, prospective data evaluating outcomes with newer...

Subject

Medicine

Cardiology

Stenosis

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!